Biochemical Society
Augustin Amour is a highly experienced scientific consultant with a robust background in drug discovery and development, currently serving at Kuano and Amour Scientific Consulting. With a notable tenure at GSK, Augustin led various immunology projects and was instrumental in transitioning pre-clinical data to clinical studies. As Co-Chair of the Treatment Recommendation Group for the PUMA Early Psychosis Platform Trial at the University of Oxford, Augustin emphasizes patient-centred approaches. Additional roles include guest editor for a special issue on AI applications in drug discovery and chair of the Biochemical Society’s Industrial Advisory Panel. Augustin holds a PhD in Enzymology from Paris-Sud University and has extensive academic and industry experience that informs a strategic approach to innovation in drug development.
This person is not in any teams
Biochemical Society
Founded in 1911, the Biochemical Society exists to advance molecular bioscience, promoting its importance as an academic discipline, from grassroots level to government policy, and highlighting its role in positively effecting societal challenges. Offering an extensive programme of scientific meetings and training events, grants and awards, educational resources, policy work and public engagement, we provide support for researchers and scientists across all career stages. We also publish 7 journals through our wholly-owned publisher, Portland Press, disseminating world-leading research and reviews that cover the breadth of the molecular biosciences.